Quantcast

Olaratumab(Lartruvo) with Pembrolizumab (Keytruda)


#1

Lilly and Merck announced a new study combining Lartruvo and Keytruda:
https://investor.lilly.com/releasedetail.cfm?ReleaseID=1007544


#2

The study combining Olaratumab (Lartruvo) and Pembrolizumab (Keytruda) can be found here: